MediPoint: Rheumatoid Arthritis Testing - Global Analysis and Market Forecasts valued at $400 million by 2022

Rheumatoid Arthritis Testing Market to Approach $400 million by 2022, says GlobalData 
The global biosurgery market, which covers hemostats, tissue sealants, tissue adhesives, and surgical adhesion barriers, is set to rise from $6 billion in 2015 to $7.6 billion by 2022, representing a steady compound annual growth rate of 3.6%, according to research and consulting firm GlobalData.
The company’s latest report* states that drivers of this growth, which will occur across 15 major markets, include aging populations in many countries, rising disease rates that necessitate a greater number of surgical interventions, and improving healthcare infrastructures in emerging countries that allow for more advanced therapies to be adopted.
Shashank Settipalli, GlobalData’s Analyst covering Medical Devices, explains: “Emerging markets, particularly large ones such as India and China, have significant untapped potential in expanding the worldwide surgical devices market. As incomes and living standards in these nations continue to rise, a greater segment of the world’s population demands better healthcare.

“This trend entails greater volumes of procedures being performed in nearly every specialty because more people can afford surgeries that were previously prohibitively expensive, increasing the need for surgical tools and accessories.”
Another driver is the need to curtail the impact of excessive blood loss, which is second only to head injury as the leading cause of death in trauma cases. In this way, devices such as hemostats, surgical sealant, and tissue adhesives can play an indispensable role in the operative phase of trauma management, and will become more widely used as need increases.
Settipalli continues: “As well as increased use of this kind of equipment, higher-cost materials will also see greater uptake. Fibrin biosurgery products, for example, have become adept hemostats, internal surgical sealants, and external tissue adhesives, and their uptake will drive the overall biosurgery market.
“Clinicians have known about fibrin’s capability as an effective hemostat and sealant for over a century, but major regulatory authorities, such as the FDA, have approved market entry relatively recently. As the number of clinical trials demonstrating fibrin’s effectiveness in a wider variety of fields expands, regulatory approval increases for greater indication coverage and companies gain access to a larger base of customers.”

Receive copy of sample report at : https://marketreportscenter.com/request-sample/387652

*MediPoint: Rheumatoid Arthritis Testing – Global Analysis and Market Forecasts
This report provides analysis of the rheumatoid arthritis testing space across the 15 major markets of the US, France, Germany, Italy, Spain, the UK, Japan, Australia, Brazil, Canada, China, India, Mexico, Russia, and South Korea, including annualized market data from 2015 and forecast until 2022.
This report was built using data and information sourced from proprietary databases, primary and secondary research, and in-house analysis conducted by GlobalData’s team of industry experts.
MediPoint: Rheumatoid Arthritis Testing – Global Analysis and Market Forecasts

Summary

Rheumatoid Arthritis (RA) is the commonest autoimmune disease in humans. The disease is prevalent in all ethnic groups, affecting approximately 1.0% of the world population. Presently there is a huge presence of unmet patient needs for both the treatment and diagnosis.

Focus for the treatment paradigm has now shifted towards the early detection and diagnosis of the disease, which will allow physicians to begin aggressive treatment of the condition, minimizing the associated complications and tissue damage.

Global sales of $347m in 2016 and estimated growth rate of 2% during the forecast period; the emerging markets: Brazil, Canada, China and Mexico are expected to show the fastest growth.

Key market drivers - 
- Increasing prevalence of autoimmune diseases globally including RA
- Emerging biomarkers and advancement in technology for the early diagnosis of RA
- Increasing adoption of anti-cyclic citrullinated peptide (anti-CCP) antibody test
- Rising demand for lab automation

Key market barriers - 
- Limited sensitivity of existing RA diagnostic tests
- Healthcare cost-cutting and reduced reimbursement in major markets

Highlights

Key Questions Answered

- What is the current and future RA testing market outlook in the developed and emerging markets? What trends are affecting the global market?
- What is the competitive landscape and who are major players in the RA testing space?
- What are the key, high growth markets that IVD manufacturers should expand into? Which market segments are growing the fastest?
- What are the unmet needs with the RA tests currently on the market? How will emerging technologies such as POC assays fulfil these unmet needs?
- What are the key products and pipelines in the RA testing market?
- What are the challenges and barriers that have hindered widespread adoption of RA tests in different regions?

Scope

- Competitive assessment: Currently marketed RA diagnostic products and evolving competitive landscape
- In-depth analysis of unmet needs and adoption trends of different RA diagnostic tests
- Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
- Pipeline analysis: Emerging products and technologies.
- Annualized total RA testing market revenue by segment and market outlooks by country from 2013-2022.
- Other key topics covered include strategic competitive assessment, market characterization, identification of unmet needs, market dynamics, and implications of the emerging technologies on the market.

Browse full report with TOC at : https://marketreportscenter.com/reports/387652/medipoint-rheumatoid-arthritis-testing-global-analysis-and-market-forecasts

Reasons to buy

The report will enable you to - 
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline
- Develop business strategies by understanding the trends shaping and driving the global market
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Track device sales in the global market from 2012-2021
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships

Receive Discount at : https://marketreportscenter.com/request-discount/387652

Media contacts:
Sam Collins
Market Reports Center
Call : 1-646-883-3044 (US)
Email : [email protected]
visit our website : https://marketreportscenter.com